NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK WARRANTS (Tables)

COMMON STOCK WARRANTS (Tables)

9 Months Ended

Jun. 30, 2014

Below is a table summarizing the warrants issued and outstanding as of June 30, 2014:

Date	Number			Exercise		Contractual		Expiration
Issued	Outstanding			Price		Life (Years)		Date
Balance 9/30/2013		5,860,934			2.77
10/1/2013		100,000			7.96		3		10/1/2016
10/31/2013		(55,556	)		3.60
12/30/2013		26,667			7.94		3		12/30/2016
1/2/2014		20,550			7.88		5		1/2/2019
1/7/2014		100,000			7.94		3		1/7/2017
2/25/2014		(30,741	)		10.0
2/25/2014		(7,200	)		3.60
2/25/2014		(16,667	)		3.60
3/26/2014		(500	)		1.50
3/31/2014		(2,130,092	)		2.51
4/8/2014		(14,815	)		3.60
4/16/2014		(3,334	)		1.65
4/16/2014		(5,652	)		6.75
6/25/2014		(50,000	)		1.20
Expired
6/30/2014		3,793,594			3.19

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details